Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis

Journal of the American Society of Nephrology

Volumn 12, Issue 9, 2001, Pages 1958-1964

  Glicklich, D ^a   Burris, L ^a   Urban, A ^a   Tellis, V ^a   Greenstein, S ^a   Schechner, R ^a   Devarajan, P ^a   Croizat, H ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FOSINOPRIL; LISINOPRIL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CLONOGENESIS; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFECT; ENZYME INHIBITION; ERYTHROCYTOSIS; ERYTHROID PRECURSOR CELL; FEMALE; HEMATOCRIT; HUMAN; HUMAN CELL; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0034867323     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia
2. Post transplant erythrocytosis: An enigma revisited
3. Angiotensin converting enzyme inhibition in the treatment of renal transplant erythrocytosis
4. Effects of erythropoietin, angiotensin II and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with post transplant erythrocytosis
5. Angiotensin as a renal growth promoting factor
6. 2 receptors
7. Angiotensin II signaling in vascular smooth muscle. New concepts
8. Angiotensin II stimulates proliferation of normal early erythroid progenitors
9. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in post transplant erythrocytosis
10. Enalapril treatment of post transplant erythrocytosis: Efficacy independent of circulating erythropoietin levels
11. Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients
12. Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-1 and its binding proteins
13. Apoptosis in vasculature of spontaneously hypertensive rats - Effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist
14. Does Captopril have a direct pro-apoptotic effect?
15. Developmental consequences of the renin-angiotensin system
16. The molecular mechanism of erythropoietin action
17. Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units
18. Heterogeneity in the properties of burst-forming units of erythroid lineage in sickle cell anemia
19. Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis
20. Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells
21. Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor 1 in vitro: Studies in an improved serum-free medium
22. Identification and characterization of an 8-kd peptide stimulating erythropoiesis
23. The N-terminal sequence of the major erythropoietic factor of an anephric patient is identical to insulin-like growth factor 1
24. Subtherapeutic erythropoietin and insulin-like growth factor 1 correct the anemia of chronic renal failure in the mouse
25. The role of insulin and insulin-like growth factor 1 in regulating human erythropoiesis. Studies in vitro under serum-free conditions: Comparison to other cytokines and growth factors
26. Insulin-like growth factor 1 plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis
27. Insulin-like growth factor 1 - A modulator of erythropoiesis in uremic patients
28. Erythropoiesis after withdrawal of enalapril in post transplant erythrocytosis kidney
29. Multiple site estimates of erythropoietin and renin in polycythemic kidney transplant patients
30. The beneficial effect of enalapril on erythrocytosis after renal transplantation
31. Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients
32. Factors predisposing to post transplant erythrocytosis
33. Enalapril treatment of post transplant erythrocytosis efficacy independent of circulating erythropoietin levels
34. Cyclosporine and the renin-angiotensin axis
35. Apoptotic mechanisms in acute renal failure
36. Biology of erythropoiesis, erythroid differentiation and maturation
37. Distinct roles of JNKs/P38 MAP Kinase and ERKs in apoptosis and survival of HCD- 57 cells induced by withdrawal or addition of erythropoietin